{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:59:13Z","timestamp":1788587953325,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T00:00:00Z","timestamp":1388361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/npp.2013.349","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T08:40:18Z","timestamp":1388392818000},"page":"1498-1507","source":"Crossref","is-referenced-by-count":40,"title":["Amphetamine-Induced Dopamine Release and Neurocognitive Function in Treatment-Naive Adults with ADHD"],"prefix":"10.1038","volume":"39","author":[{"given":"Mariya V","family":"Cherkasova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazlie","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A","family":"O'Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Hechtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"Joober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Leyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawki","family":"Benkelfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"BFnpp2013349_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","volume":"85","author":"GE Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD, DeLong MR (1990). Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u2018prefrontal\u2019 and \u2018limbic\u2019 functions. Prog Brain Res 85: 119\u2013146.","journal-title":"Prog Brain Res"},{"key":"BFnpp2013349_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00213-010-1912-x","volume":"211","author":"A-A Allman","year":"2010","unstructured":"Allman A-A, Benkelfat C, Durand F, Sibon I, Dagher A, Leyton M et al (2010). Effect of d-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology 211: 423\u2013433.","journal-title":"Psychopharmacology"},{"key":"BFnpp2013349_CR3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0006-3223(03)00609-7","volume":"54","author":"AR Aron","year":"2003","unstructured":"Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003). Methylphenidate improves response inhibition in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry 54: 1465\u20131468.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1056-8719(02)00167-3","volume":"46","author":"SJ Asghar","year":"2002","unstructured":"Asghar SJ, Baker GB, Rauw GA, Silverstone PH (2002). A rapid method of determining amphetamine in plasma samples using pentafluorobenzenesulfonyl chloride and electron-capture gas chromatography. J Pharmacol Toxicol Methods 46: 111\u2013115.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"BFnpp2013349_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/nimg.2000.0620","volume":"12","author":"J Aston","year":"2000","unstructured":"Aston J, Gunn R, Worsley K, Ma Y, Evans AC, Dagher A (2000). A statistical method for the analysis of positron emission tomopgraphy neuroreceptor ligand data. Neuroimage 12: 245\u2013256.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/00004647-200208000-00014","volume":"22","author":"JA Aston","year":"2002","unstructured":"Aston JA, Cunningham VJ, Asselin MC, Hammers A, Evans AC, Gunn RN (2002). Positron emission tomography partial volume correction: estimation and algorithms. J Cereb Blood Flow Metab 22: 1019\u20131034.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2013349_CR7","unstructured":"Beck AT, Steer RA (1993). Manual for the Revised Beck Depression Inventory. Psychological Corporation: San Antonio, TX."},{"key":"BFnpp2013349_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archpsyc.63.12.1386","volume":"63","author":"I Boileau","year":"2006","unstructured":"Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M et al (2006). Modeling sensitization to stimulants in humans: an [11C]raclopride\/positron emission tomography study in healthy men. Arch Gen Psychiatry 63: 1386\u20131395.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013349_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.1185778","volume":"329","author":"JW Buckholtz","year":"2010","unstructured":"Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al (2010). Dopaminergic network differences in human impulsivity. Science 329: 532.","journal-title":"Science"},{"key":"BFnpp2013349_CR10","doi-asserted-by":"crossref","unstructured":"Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M (2013). Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. Biol Psychiatry e-pub ahead of print 16 October 2013 doi:10.1016\/j.biopsych.2013.08.033.","DOI":"10.1016\/j.biopsych.2013.08.033"},{"key":"BFnpp2013349_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","volume":"18","author":"DL Collins","year":"1994","unstructured":"Collins DL, Neelin P, Peters TM, Evans AC (1994). Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18: 192\u2013205.","journal-title":"J Comput Assist Tomogr"},{"key":"BFnpp2013349_CR12","volume-title":"Conners\u2019 Adult ADHD Rating Scales. Technical Manual","author":"CK Conners","year":"1999","unstructured":"Conners CK, Erhart D, Sparrow E (1999) Conners\u2019 Adult ADHD Rating Scales. Technical Manual. Multi-Health Systems: New York."},{"key":"BFnpp2013349_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.neuroimage.2009.05.052","volume":"47","author":"N Costes","year":"2009","unstructured":"Costes N, Dagher A, Larcher K, Evans AC, Collins DL, Reilhac A (2009). Motion correction of multi-frame PET data in neuroreceptor mapping: Simulation based validation. Neuroimage 47: 1496\u20131505.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1523\/JNEUROSCI.2136-12.2013","volume":"33","author":"DP Daberkow","year":"2013","unstructured":"Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, Ragozzino ME et al (2013). Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J Neurosci 33: 452\u2013463.","journal-title":"J Neurosci"},{"key":"BFnpp2013349_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1360-0443.2011.03624.x","volume":"107","author":"A Dagher","year":"2012","unstructured":"Dagher A (2012). Addiction as aberrant learning-evidence from Parkinson\u2019s disease. Addiction 107: 248\u2013250.","journal-title":"Addiction"},{"key":"BFnpp2013349_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1126\/science.1137073","volume":"315","author":"JW Dalley","year":"2007","unstructured":"Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K et al (2007). Nucleus accumbens D2\/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267\u20131270.","journal-title":"Science"},{"key":"BFnpp2013349_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1469-7610.2006.01671.x","volume":"47","author":"SG Dickstein","year":"2006","unstructured":"Dickstein SG, Bannon K, Castellanos FX, Milham MP (2006). The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 47: 1051\u20131062.","journal-title":"J Child Psychol Psychiatry"},{"key":"BFnpp2013349_CR18","first-page":"157","volume":"15","author":"W Dixon","year":"1974","unstructured":"Dixon W, Yuen K (1974). Trimming and winsorization: a review. Stat Papers 15: 157\u2013170.","journal-title":"Stat Papers"},{"key":"BFnpp2013349_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-8986.00063","volume":"40","author":"U Ettinger","year":"2003","unstructured":"Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ (2003). Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology 40: 1\u20139.","journal-title":"Psychophysiology"},{"key":"BFnpp2013349_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.psc.2009.12.004","volume":"33","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Mick E (2010). Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 33: 159\u2013180.","journal-title":"Psychiatr Clin North Am"},{"key":"BFnpp2013349_CR21","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute: New York."},{"key":"BFnpp2013349_CR22","first-page":"134","volume-title":"Stimulant Drugs and ADHD: Basic and Clinical Neuroscience","author":"AA Grace","year":"2001","unstructured":"Grace AA (2001). Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD. In: Solanto M, Arnsten AF, Castellanos FX (eds) Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Oxford University Press: New York. pp 134\u2013157."},{"key":"BFnpp2013349_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nimg.1997.0303","volume":"6","author":"RN Gunn","year":"1997","unstructured":"Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997). Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6: 279\u2013287.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR24","first-page":"38","volume-title":"Dopamine Handbook","author":"SN Haber","year":"2010","unstructured":"Haber SN (2010). Convergence of limbic, cognitive, and motor cortico-striatal circuits with dopamine pathways in the primate brain. In: Iversen L, Iversen SD, Dunnett SB, Bjorklund A (eds) Dopamine Handbook. Oxford University Press: Oxford. pp 38\u201348."},{"key":"BFnpp2013349_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/0042-6989(78)90218-3","volume":"18","author":"PE Hallett","year":"1978","unstructured":"Hallett PE (1978). Primary and secondary saccades to goals defined by instructions. Vision Res 18: 1279\u20131296.","journal-title":"Vision Res"},{"key":"BFnpp2013349_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1152\/physrev.2000.80.3.953","volume":"80","author":"O Hikosaka","year":"2000","unstructured":"Hikosaka O, Takikawa Y, Kawagoe R (2000). Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80: 953\u2013978.","journal-title":"Physiol Rev"},{"key":"BFnpp2013349_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533\u20131539.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2013349_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A","volume":"31","author":"LS Kegeles","year":"1999","unstructured":"Kegeles LS, Zea-Ponce Y, Abi-Dargham A, Rodenhiser J, Wang T, Weiss R et al (1999). Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans. Synapse 31: 302\u2013308.","journal-title":"Synapse"},{"issue":"3 Pt 1","key":"BFnpp2013349_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. Neuroimage 4 (3 Pt 1): 153\u2013158.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000). Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20: 423\u2013451.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2013349_CR31","first-page":"129","volume":"32","author":"M Leyton","year":"2007","unstructured":"Leyton M, aan het Rot M, Booij L, Baker GB, Young SN, Benkelfat C (2007). Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci 32: 129\u2013136.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2013349_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1037\/0096-1523.10.2.276","volume":"10","author":"GD Logan","year":"1984","unstructured":"Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276\u2013291.","journal-title":"J Exp Psychol Hum Percept Perform"},{"key":"BFnpp2013349_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1469-8749.2004.tb00469.x","volume":"46","author":"HC Lou","year":"2004","unstructured":"Lou HC, Rosa P, Pryds O, Karrebaek H, Lunding J, Cumming P et al (2004). ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow. Dev Med Child Neurol 46: 179\u2013183.","journal-title":"Dev Med Child Neurol"},{"key":"BFnpp2013349_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2013349_CR35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2006.01.008","volume":"59","author":"CA Munro","year":"2006","unstructured":"Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J et al (2006). Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59: 966\u2013974.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR36","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.biopsych.2004.11.011","volume":"57","author":"JT Nigg","year":"2005","unstructured":"Nigg JT (2005). Neuropsychologic theory and findings in attention-deficit\/hyperactivity disorder: the sate of the field and salient challenges for the coming decade. Biol Psychiatry 57: 1424.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1207\/s15324826an0604_7","volume":"6","author":"BM Pilgrim","year":"1999","unstructured":"Pilgrim BM, Meyers JE, Bayless J, Whetstone MM (1999). Validity of the Ward seven-subtest WAIS-III short form in a neuropsychological population. Appl Neuropsychol 6: 243\u2013246.","journal-title":"Appl Neuropsychol"},{"key":"BFnpp2013349_CR38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/ajp.155.6.768","volume":"155","author":"T Pohjalainen","year":"1998","unstructured":"Pohjalainen T, Rinne JO, N\u00e5gren K, Syv\u00e4lahti E, Hietala J (1998). Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 155: 768\u2013773.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013349_CR39","first-page":"111","volume":"5","author":"CR Reynolds","year":"1983","unstructured":"Reynolds CR, Willson VL, Clark PL (1983). A four-test short-form of the WAIS-R for clinical screening. Clin Neuropsychol 5: 111\u2013116.","journal-title":"Clin Neuropsychol"},{"key":"BFnpp2013349_CR40","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1176\/ajp.2006.163.9.1639","volume":"163","author":"P Riccardi","year":"2006","unstructured":"Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B et al (2006). Sex differences in amphetamine-induced displacement of [18F]fallypride in striatal and extrastriatal regions: a PET study. Am J Psychiatry 163: 1639\u20131641.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013349_CR41","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.neuroimage.2004.11.031","volume":"25","author":"P Rosa-Neto","year":"2005","unstructured":"Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J et al (2005). Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25: 868.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled JG, Zijdenbos AP, Evans AC (1998). A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17: 87\u201397.","journal-title":"IEEE Trans Med Imaging"},{"key":"BFnpp2013349_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12402-010-0019-x","volume":"2","author":"TA Sontag","year":"2010","unstructured":"Sontag TA, Tucha O, Walitza S, Lange KW (2010). Animal models of attention deficit\/hyperactivity disorder (ADHD): a critical review. Atten Defic Hyperact Disord 2: 1\u201320.","journal-title":"Atten Defic Hyperact Disord"},{"key":"BFnpp2013349_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","volume":"57","author":"T Spencer","year":"2005","unstructured":"Spencer T, Biederman J, Madras B, Faraone S, Dougherty D, Bonab A et al (2005). In vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 57: 1293\u20131300.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","volume":"35","author":"T Spencer","year":"1996","unstructured":"Spencer T, Biederman J, Wilens T, Harding M, O\u2019Donnell D, Griffin S (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adoles Psychiatry 35: 409\u2013432.","journal-title":"J Am Acad Child Adoles Psychiatry"},{"key":"BFnpp2013349_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biopsych.2012.11.010","volume":"74","author":"TJ Spencer","year":"2013","unstructured":"Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD et al (2013). Functional genomics of attention-deficit\/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry 74: 84\u201389.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR47","doi-asserted-by":"crossref","unstructured":"Tziortzi AC, Haber SN, Searle GE, Tsoumpas C, Long CJ, Shotbolt P et al (2013). Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. Cereb Cortex e-pub ahead of print, 2 January 2013 doi:10.1093\/cercor\/bhs397.","DOI":"10.1093\/cercor\/bhs397"},{"key":"BFnpp2013349_CR48","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.neuroimage.2006.10.014","volume":"34","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang G-J, Newcorn J, Fowler JS, Telang F, Solanto MV et al (2007a). Brain dopamine transporter levels in treatment and drug na\u00efve adults with ADHD. Neuroimage 34: 1182.","journal-title":"Neuroimage"},{"key":"BFnpp2013349_CR49","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","volume":"64","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang G-J, Newcorn J, Telang F, Solanto MV, Fowler JS et al (2007b). Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 64: 932\u2013940.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013349_CR50","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.biopsych.2004.11.006","volume":"57","author":"ND Volkow","year":"2005","unstructured":"Volkow ND, Wang GJ, Fowler JS, Ding YS (2005). Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit\/hyperactivity disorder. Biol Psychiatry 57: 1410\u20131415.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013349_CR51","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2009.1308","volume":"302","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F et al (2009). Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302: 1084\u20131091.","journal-title":"JAMA"},{"key":"BFnpp2013349_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O","volume":"4","author":"KJ Worsley","year":"1996","unstructured":"Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996). A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4: 58\u201373.","journal-title":"Hum Brain Mapp"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013349","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:16:43Z","timestamp":1746080203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,30]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFnpp2013349"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.349","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718220064.793489156","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,30]]}}}